Stonebridge Capital Management Inc. purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 13,790 shares of the company’s stock, valued at approximately $1,772,000. Merck KGaA accounts for 0.9% of Stonebridge Capital Management Inc.’s holdings, making the stock its 28th largest position.
Other large investors also recently modified their holdings of the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Merck KGaA during the second quarter worth about $942,087,000. Whalen Wealth Management Inc. purchased a new position in shares of Merck KGaA during the second quarter worth about $1,600,000. Cibc World Market Inc. bought a new position in shares of Merck KGaA in the second quarter worth approximately $186,005,000. Madison Wealth Partners Inc purchased a new stake in Merck KGaA in the second quarter valued at approximately $1,031,000. Finally, Keating Financial Advisory Services Inc. bought a new stake in Merck KGaA during the second quarter valued at approximately $592,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $164.58 on Thursday. The company’s fifty day moving average price is $163.19 and its 200-day moving average price is $148.83. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96. Merck KGaA has a one year low of $116.68 and a one year high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
